José Luis Subiza is the founder and CEO-president of Inmunotek SL, a pharmaceutical company. He received his medical degree from the Complutense University of Madrid and his PhD from the Autonomous University of Madrid.  He worked in the Department of Immunology at the Hospital Clínico San Carlos in Madrid.  His research interests have focused on therapeutic vaccines in the fields of allergology, oncology, and clinical immunology.